Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aase Handberg

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Frontiers in Physiology|February 21, 2024
Comprehensive strategy for identifying extracellular vesicle surface proteins as biomarkers for chronic kidney diseaseNahuel Aquiles Garcia, Hernan Gonzalez-King, Maiken Mellergaard, et al.
The Journal of Nutritional Biochemistry|September 16, 2008
Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose toleranceJose-Manuel Fernández-Real, Aase Handberg, Francisco Ortega, et al.
Biomedicines|March 6, 2021
Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV PopulationsRikke W Rasmussen, Jaco Botha, Frederik Prip, et al.
Diabetes Care|November 15, 2007
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatmentDorte Glintborg, Kurt Højlund, Marianne Andersen, et al.
Plos One|September 27, 2013
Circulating CD36 is reduced in HNF1A-MODY carriersSiobhan Bacon, Ma P Kyithar, Jasmin Schmid, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 20, 2021
Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: A population-based cohort studySøren Schou Olesen, Abdulkarim Harakow, Klaus Krogh, et al.
Marine Drugs|September 4, 2013
The effect of low-dose marine n-3 fatty acids on plasma levels of sCD36 in overweight subjects: a randomized, double-blind, placebo-controlled trialStine Krogh Venø, Michael René Skjelbo Nielsen, Søren Lundbye-Christensen, et al.
Biochemical and Biophysical Research Communications|June 15, 2004
The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3alpha activity in diabetic myotubesMichael Gaster, Klaus Brusgaard, Aase Handberg, et al.
Diabetes & Vascular Disease Research|January 22, 2009
Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant menAase Handberg, Abel Lopez-Bermejo, Judit Bassols, et al.
Atherosclerosis|September 16, 2018
Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and womenYeli Wang, Jingwen Zhu, Aase Handberg, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Frontiers in Physiology|February 21, 2024
Comprehensive strategy for identifying extracellular vesicle surface proteins as biomarkers for chronic kidney diseaseNahuel Aquiles Garcia, Hernan Gonzalez-King, Maiken Mellergaard, et al.
The Journal of Nutritional Biochemistry|September 16, 2008
Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose toleranceJose-Manuel Fernández-Real, Aase Handberg, Francisco Ortega, et al.
Biomedicines|March 6, 2021
Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV PopulationsRikke W Rasmussen, Jaco Botha, Frederik Prip, et al.
Diabetes Care|November 15, 2007
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatmentDorte Glintborg, Kurt Højlund, Marianne Andersen, et al.
Plos One|September 27, 2013
Circulating CD36 is reduced in HNF1A-MODY carriersSiobhan Bacon, Ma P Kyithar, Jasmin Schmid, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 20, 2021
Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: A population-based cohort studySøren Schou Olesen, Abdulkarim Harakow, Klaus Krogh, et al.
Marine Drugs|September 4, 2013
The effect of low-dose marine n-3 fatty acids on plasma levels of sCD36 in overweight subjects: a randomized, double-blind, placebo-controlled trialStine Krogh Venø, Michael René Skjelbo Nielsen, Søren Lundbye-Christensen, et al.
Biochemical and Biophysical Research Communications|June 15, 2004
The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3alpha activity in diabetic myotubesMichael Gaster, Klaus Brusgaard, Aase Handberg, et al.
Diabetes & Vascular Disease Research|January 22, 2009
Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant menAase Handberg, Abel Lopez-Bermejo, Judit Bassols, et al.
Atherosclerosis|September 16, 2018
Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and womenYeli Wang, Jingwen Zhu, Aase Handberg, et al.
Pageof 11